The Effects of Puerariae Radix on Allergic Inflammation

갈근추출액이 알레르기 염증반응에 미치는 영향

  • Kim, Hong-Bae (Department of Pediatrics, College of Oriental Medicine, Dongeui University) ;
  • Kang, Kyung-Hwa (Department of Physiology, College of Oriental Medicine, Dongeui University) ;
  • Hwang, Won-Deuk (Department of Internal Medicine, College of Oriental Medicine, Dongeui University) ;
  • Lyu, Sun-Ae (Department of Pediatrics, College of Oriental Medicine, Dongeui University) ;
  • Lee, Seung-Yeon (Department of Pediatrics, College of Oriental Medicine, Dongeui University)
  • 김홍배 (동의대학교 한의과대학 소아과학교실) ;
  • 강경화 (동의대학교 한의과대학 생리학교실) ;
  • 황원덕 (동의대학교 한의과대학 내과학교실) ;
  • 유선애 (동의대학교 한의과대학 소아과학교실) ;
  • 이승연 (동의대학교 한의과대학 소아과학교실)
  • Published : 2009.12.31

Abstract

Objectives To evaluate that Okwada affected which factors for treatment of lung fibrosis. Methods Bleomycin induced lung fibrosis model made in mice. After Okwada lyophilized, power sample obtained and melt in distilled water. Okwada solution administered mice through oral route on 21 days after bleomycin instillation and this procedure performed once a day for 7 days. We divided by three groups; normal (control), bleomycin induced lung fibrosis without treatment (experimental), bleomycin induced lung fibrosis with treatment (treatment). On six weeks after bleomycin instillation, mice sacrificed and removed lung. We performed Western blot analysis for TGF-beta, phosphodiesterase 5A, interleukin (4,5,13) and compared therapeutic effects of Okwada. Results On western blot analysis, all normal and experimental mice detected TGF-beta, phosphodiesterase 5A, interleukin 4,5,13. The amount of band of TGF-beta, phosphodiesterase 5A, interleukin 5 in experimental and treatment group was similar. However, interleukin 4,13 of treatment group decreased compared with experimental group. Conclusions Okwada would be effected the lung fibrosis through suppression of interleukin 4,13.

Keywords

References

  1. 홍창의. 소아과학. 서울. 대한 교과서주식회사. 1987:612-4.
  2. 이진용, 김덕곤. 아포피 피부염 환자 67명에 대한 임상적 고찰. 대한한방소아과학회지. 1993;7(1):121-33.
  3. 김정원. 아토피피부염의 진단과 치료. 대한 알레르기학회지. 1993;13(3):84-90.
  4. 고백화. 實用中醫外科學. 上海. 上海科學技術出版社. 1985:460-4.
  5. 김미정, 이승연. 소아 아토피 피부염에 대한 문헌적 고찰. 대한한방소아과학회지. 2000;14(2):167-82.
  6. 신민교 편저, 임상본초학, 서울. 영림사, 2002:341-43.
  7. 손성연집. 神農本草經. 서울. 경희대학교출판국. 1968:7.
  8. 雷裁權外 共編. 中華臨床中藥學. 上海. 人民衛生出版社. 1998:330-3.
  9. 康秉秀外 共著. 方劑의 體系的 構成을 위한 臨床配合本草學. 서울. 영림사. 1994:477-9.
  10. 楊濟 外 共編. 臨證用藥配伍指南. 北京. 中國醫藥科技出版社. 1996:67-9.
  11. 周鳳梧. 古今醫方縱橫. 北京. 人民衛生出版社. 1996:26-34.
  12. 梁基相. 漢藥의 配合과 臨床應用. 서울. 傳統醫學硏究所. 1993:64-6.
  13. S. Katayama, H. Shionoya and S. Ohtake: A new method for extraction of extravasated dye in the skin and the influence of fasting stress on passive cutaneous allergy in guinea pigs and rats. Microbiol. Immunol. 1978;22:89-101. https://doi.org/10.1111/j.1348-0421.1978.tb00352.x
  14. Dastych J, Walczak-Drzewiecka A, Wyczolkowska J, Metcalfe DD. Murine mast cells exposed to mercuric chloride release granuleassociated N-acetyl-beta-d-hexosaminidase and secrete IL-4 and TNF-alpha. J Allergy Clin Immunol 1999;103:1108-14. https://doi.org/10.1016/S0091-6749(99)70186-7
  15. Schwartz LB, Austen KF, Wasserman SI. Immunologic release of beta-hexosaminidase and beta-glucuronidase from purified rat serosal mast cells. J Immunol 1979;123:1445-50.
  16. 이혜란. 아토피 피부염. 소아과학회지. 2006;43(9):1161-7.
  17. 신상호, 김자혜, 김미보, 윤화정, 유선애, 이승연, 이미염, 김규곤, 고우신. 승갈탕을 사용한 아토피 피부염 환자에 대한 임상시험. 한방안이비인후피부과학회지. 2007;20(2): 199-212.
  18. 양성완. 수종 한약처방이 아토피 피부염 환자에서 SCORAD 및 Cytokine 변화에 미치는 영향. 서울. 경희대학교 대학원. 2004.
  19. 강병수, 김영판. 임상배학본초학. 서울. 영림사. 1994:477-9.
  20. 중화 본초편찬위. 중화본초. 상해. 상해과학기술출판사. 2002: 610-19.
  21. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2008;8:183-92. https://doi.org/10.1038/nri2254
  22. Dainaka J, Ichikawa A, Koibuchi Y, Nakagawa M, Tomita K. Effect of the tridecamer of compound 48/80, a $Ca^{2+}$-dependent histamine releaser, on phospholipid metabolism during the early stage of histamine release from rat mast cells. Biochem Pharmacol 1986;35(21):3739-44. https://doi.org/10.1016/0006-2952(86)90659-3
  23. White, D.H., K. Pluzmik and T. Ishizaka. Antigen-induced increase in protein kinase C activity in plasma membrane of mast cells. Proc. Nati. Acad. Sci. USA 1986;82:8139-97. https://doi.org/10.1073/pnas.82.23.8139
  24. Vane, J. A. (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like durgs. Nat. New. Biol., 23:232-5.
  25. Funk, C. D., Frunk, L. B., Kennedy, M. E., Pong, A. S. and Fitzgerald, G. A. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J., 1991;5: 2304-12.
  26. Weis, Z. A., Cicatiello, L. and Esumi, H. Regulation of the mouse inducible-type nitric oxide synthase gene promoter by interferon-gamma, bacterial lipopolysaccharide and NG-monomethyl-L-arginine. Biochem J., 1996; 316:209-15. https://doi.org/10.1042/bj3160209
  27. Ryu, J. H. Ahn, H. Kim, J. Y. and Kim, Y. K. Inhibitory activity of plant extracts on nitric oxide synthesis in LPS-activated macrophage. Phytother Res., 2003;17:485-9. https://doi.org/10.1002/ptr.1180
  28. Mu, M. M., Chakravortty, D., Sugiyama, T., Koide, N., Takahashi, K., Mori, I., Yoshida, T. and Yokochi, T. The inhibitory action of quercetin on lipopolysaccharide-induced nitricoxide production in RAW 264.7 macrophage cells. J. Endotoxin Res., 2001;7:431-8. https://doi.org/10.1177/09680519010070060601
  29. Masferrer, J., Zweifel B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson. P. C. and Seibert, K. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci ., 1994;91:3228-32. https://doi.org/10.1073/pnas.91.8.3228
  30. Seibert, K., Zhang, Y., Leahy, K., Hauser, S, Masferrer, J., Perkins, W., Lee, L. and Isakson, P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci . USA, 1994;91:12013-7. https://doi.org/10.1073/pnas.91.25.12013
  31. Kim, J. Y., Jung, K. S. and Jeong, H. G.Suppressive effects of the kahweol andcafestol on cycloocygenase-2 expression in macrophages. FEBS Letters, 2004;569:321-6. https://doi.org/10.1016/j.febslet.2004.05.070
  32. Marquardt DL, Wasserman SI. Modulation of rat serosal mast cell biochemistry by in vivo dexamethasone administration. J Immunol. 1983;131:934-9.
  33. Mastuda H, Morikawa T, Ueda K, Managi H, Yoshikawa M. Structural requirements of flavonoids for inhibition of antigen-Induced degranulation, TNF-alpha and IL-4 production from RBL-2H3 cells. Bioorg Med Chem. 2002;10:3123-8. https://doi.org/10.1016/S0968-0896(02)00227-4
  34. Iikura M, Yamaguchi M, Hirai K, Miyamasu M, Yamada H, Nakajima T, Fujisawa T, Ra C, Morita Y, Yamamoto K. Regulation of surface FcepsilonRI expression on human eosinophils by IL-4 and IgE. Int Arch Allergy Immunol. 2001;124:470-7. https://doi.org/10.1159/000053782
  35. 이중달. 그림으로 설명한 병리학. 서울, 고려의학. 1991:29.
  36. Gilchrist, M., Savoie, M., Nohara, O., Wills, F. L., Wallace, J. L., and Befus, A. D. J. Leukocyte Biol. 2002;71:618-24.
  37. Careau E, Sirois J, Bissonnette EY. Characterization of lung hyperresponsiveness, inflammation, and alveolar macrophage mediator production in allergy resistant and susceptible rats. Am J Respir Cell Mol Biol. 2002;26: 579-86. https://doi.org/10.1165/ajrcmb.26.5.4737